BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8835602)

  • 1. Late onset bone marrow transplant nephropathy.
    Oyama Y; Komatsuda A; Imai H; Ohtani H; Hamai K; Wakui H; Miura AB; Nakamoto Y
    Intern Med; 1996 Jun; 35(6):489-93. PubMed ID: 8835602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation.
    Tarbell NJ; Guinan EC; Chin L; Mauch P; Weinstein HJ
    Radiother Oncol; 1990; 18 Suppl 1():139-42. PubMed ID: 2247640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
    Hwang WY; Goh YT; Tan CH; How GF; Tan HC
    Bone Marrow Transplant; 2000 Jan; 25(2):205-7. PubMed ID: 10673682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice. Role of pretransplant radiation conditioning.
    Shankar G; Scott Bryson J; Darrell Jennings C; Kaplan AM; Cohen DA
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1116-24. PubMed ID: 10340930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed renal failure with extensive mesangiolysis following bone marrow transplantation.
    Antignac C; Gubler MC; Leverger G; Broyer M; Habib R
    Kidney Int; 1989 Jun; 35(6):1336-44. PubMed ID: 2671466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML.
    Messner HA; Curtis JE; Minden MM
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):187-9. PubMed ID: 3892701
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation.
    Lawton CA; Fish BL; Moulder JE
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):883-9. PubMed ID: 8138441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortality.
    Hjiyiannakis P; Mehta J; Milan S; Powles R; Hinson J; Tait D
    Leuk Lymphoma; 1997 May; 25(5-6):565-72. PubMed ID: 9250828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
    Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
    Zenz T; Schlenk RF; Glatting G; Neumaier B; Blumstein N; Buchmann I; von Harsdorf S; Ringhoffer M; Wiesneth M; Keller F; Kotzerke J; Röttinger E; Stilgenbauer S; Döhner H; Reske SN; Bunjes D
    J Nucl Med; 2006 Feb; 47(2):278-86. PubMed ID: 16455634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia.
    Wang WS; Tzeng CH; Hsieh RK; Chiou TJ; Liu JH; Yen CC; Chen PM
    Bone Marrow Transplant; 1998 Feb; 21(4):415-7. PubMed ID: 9509978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
    Miralbell R; Sancho G; Bieri S; Carrió I; Helg C; Brunet S; Martin PY; Sureda A; Gomez De Segura G; Chapuis B; Estorch M; Ozsahin M; Keller A
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):809-16. PubMed ID: 14967438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.